AMPH — AMPHASTAR PHARMACEUTICALS IN

Ownership history in nVerses Capital, LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in AMPHASTAR PHARMACEUTICALS IN (AMPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.17% (2024 Q1)
Avg. % of fund
0.07%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 2,600 — 0% 0.06% $126K $26.65
2025 Q2 UNCHANGED 2,600 — 0% 0.06% $126K $22.96
2025 Q1 UNCHANGED 2,600 — 0% 0.06% $126K $28.99
2024 Q4 UNCHANGED 2,600 — 0% 0.06% $126K $37.13
2024 Q3 ADDED 2,600 +400 +18.2% 0.06% $126K $48.53
2024 Q2 ADDED 2,200 +600 +37.5% 0.05% $88K $40.00
2024 Q1 INITIATED 1,600 — — 0.17% $70K —
% of Fund (quarterly)    AMPH price (monthly, adj. close)

Other funds also holding AMPH

As of 2025 Q4 — sorted by position size

LAM GROUP, INC. 3Y 2.0% Bridge City Capital, LLC 3Y 7Y 1.85% Quantedge Capital Pte Ltd 3Y 1.17% DENALI ADVISORS LLC 3Y 7Y 0.63% SummerHaven Investment Management, LLC 3Y 0.58% Significant Wealth Partners LLC 0.29% SYSTEMATIC FINANCIAL MANAGEMENT LP 3Y 7Y 0.27% Corient IA LLC 0.19% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.18% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 0.18%
← Back to nVerses Capital, LLC Holdings